Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 10, 2014 - Issue 10
Submit an article Journal homepage
412
Views
10
CrossRef citations to date
0
Altmetric
Reviews

Some considerations on the predictions of pharmacokinetic alterations in subjects with liver disease

Martha GonzalezJanssen PRD, Clinical Pharmacology, 920 Route 202 South, Raritan, NJ 08869, [email protected]
,
Laura GoracciUniversity of Perugia, Chemistry and Biology and Biotechnology, Perugia, Italy
,
Gabriele CrucianiUniversity of Perugia, Chemistry and Biology and Biotechnology, Perugia, Italy
&
Italo PoggesiJanssen, Clinical Pharmacology/Modeling & Simulation, Via Buonarroti,23, Cologno Monzese, Cologno Monzese (MI), 20093, Italy
Pages 1397-1408 | Published online: 15 Sep 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Tirsit Ketsela Zeleke, Zegaye Agmassie Bazezew & Rahel Belete Abebe. (2023) The Burden of Inappropriate Prescriptions and Predictors for Hospitalized Patients with Liver Cirrhosis in Ethiopia. Hepatic Medicine: Evidence and Research 15, pages 129-140.
Read now
Rianne A. Weersink, David M. Burger, Kelly L. Hayward, Katja Taxis, Joost P.H. Drenth & Sander D. Borgsteede. (2020) Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations. Expert Opinion on Drug Metabolism & Toxicology 16:1, pages 45-57.
Read now

Articles from other publishers (8)

Katharina Karsten Dafonte, Lisa Weber, Florian Chmielewski, Anna Maria Böhmer, Philipp Lutz, Gunther Hartmann, Ulrich Jaehde & Martin Coenen. (2023) Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature Review. Clinical Drug Investigation 43:7, pages 475-502.
Crossref
Hafsa Hafsa, Ammara Zamir, Muhammad Fawad Rasool, Imran Imran, Hamid Saeed, Tanveer Ahmad, Sary Alsanea, Ali A. Alshamrani, Abdullah H. Alruwaili & Faleh Alqahtani. (2022) Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations. Pharmaceutics 14:11, pages 2362.
Crossref
Icaro Salgado Perovani, Maike Felipe Santos Barbetta, Rodrigo Moreira da Silva, Norberto Peporine Lopes & Anderson Rodrigo Moraes de Oliveira. (2022) In vitro-in vivo correlation of the chiral pesticide prothioconazole after interaction with human CYP450 enzymes. Food and Chemical Toxicology 163, pages 112947.
Crossref
Arduino A. Mangoni & Elzbieta A. Jarmuzewska. (2021) Incorporating pharmacokinetic data into personalised prescribing for older people: challenges and opportunities. European Geriatric Medicine 12:3, pages 435-442.
Crossref
Icaro Salgado Perovani, Daniel Blascke Carrão, Nayara Cristina Perez de Albuquerque & Anderson Rodrigo Moraes de Oliveira. (2020) Enantioselective in vitro metabolism and in vitro-in vivo correlation of the herbicide ethofumesate in a human model. Journal of Pharmaceutical and Biomedical Analysis 187, pages 113349.
Crossref
Ejaz Cheema, Aliaa Al-Aryan & Abdullah Al-Hamid. (2019) Medicine use and medicine-related problems in patients with liver cirrhosis: a systematic review of quantitative and qualitative studies. European Journal of Clinical Pharmacology 75:8, pages 1047-1058.
Crossref
Dan Tang, Bai‐Li Song, Miao Yan, Jian‐Jun Zou, Min Zhang, Hua‐Ying Zhou, Feng Wang, Yi‐Wen Xiao, Ping Xu, Bi‐Kui Zhang, Xi‐Jing Chen, Da‐Xiong Xiang & Hoan Linh Banh. (2019) Identifying factors affecting the pharmacokinetics of voriconazole in patients with liver dysfunction: a population pharmacokinetic approach. Basic & Clinical Pharmacology & Toxicology.
Crossref
Ilse R. Dubbelboer, Erik Sjögren & Hans Lennernäs. (2018) Porcine and Human In Vivo Simulations for Doxorubicin-Containing Formulations Used in Locoregional Hepatocellular Carcinoma Treatment. The AAPS Journal 20:6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.